Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

ClinicalTrials.gov ID: NCT03815825

Public ClinicalTrials.gov record NCT03815825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 3:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized Placebo-Controlled, Double-Masked Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluate the effect of IONIS-FB-LRx on the rate of change of the area of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) measured by fundus autofluorescence (FAF).

Study identification

NCT ID
NCT03815825
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ionis Pharmaceuticals, Inc.
Industry
Enrollment
332 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2019 (Actual)
Primary completion
Apr 18, 2024 (Actual)
Completion
Jun 12, 2024 (Actual)
Last update posted
Mar 7, 2025

2019 – 2024

United States locations

U.S. sites
55
U.S. states
20
U.S. cities
50
Facility City State ZIP Site status
IONIS Investigative Site Phoenix Arizona 85020 —
IONIS Investigative Site Phoenix Arizona 85021 —
IONIS Investigative Site Phoenix Arizona 85053 —
IONIS Investigative Site Sun City Arizona 85351 —
IONIS Investigative Site Beverly Hills California 90211 —
IONIS Investigative Site Huntington Beach California 92697 —
IONIS Investigative Site La Jolla California 92093 —
IONIS Investigative Site Long Beach California 90807 —
IONIS Investigative Site Poway California 92064 —
IONIS Investigative Site San Francisco California 94109 —
IONIS Investigative Site Colorado Springs Colorado 80909 —
IONIS Investigative Site Clearwater Florida 33761 —
IONIS Investigative Site Fort Myers Florida 33907 —
IONIS Investigative Site Lake Worth Florida 33461 —
IONIS Investigative Site Lakeland Florida 33801 —
IONIS Investigative Site Melbourne Florida 32901 —
IONIS Investigative Site Stuart Florida 34994 —
IONIS Investigative Site Tampa Florida 33612 —
IONIS Investigative Site Winter Haven Florida 33880 —
IONIS Investigative Site Augusta Georgia 30909 —
IONIS Investigative Site Lemont Illinois 60439 —
IONIS Investigative Site Springfield Illinois 62702 —
IONIS Investigative Site Leawood Kansas 66211 —
IONIS Investigative Site Baltimore Maryland 21204 —
IONIS Investigative Site Baltimore Maryland 21209 —
IONIS Investigative Site Hagerstown Maryland 21740 —
IONIS Investigative Site Southaven Mississippi 38671 —
IONIS Investigative Site Albuquerque New Mexico 87109 —
IONIS Investigative Site Asheville North Carolina 28803 —
IONIS Investigative Site Hickory North Carolina 28602 —
IONIS Investigative Site Winston-Salem North Carolina 27157 —
IONIS Investigative Site Cleveland Ohio 44106 —
IONIS Investigative Site Cleveland Ohio 44130 —
IONIS Investigative Site Cleveland Ohio 44195 —
IONIS Investigative Site Tulsa Oklahoma 74114 —
IONIS Investigative Site Philadelphia Pennsylvania 19104 —
IONIS Investigative Site Pittsburgh Pennsylvania 15213 —
IONIS Investigative Site West Mifflin Pennsylvania 15122 —
IONIS Investigative Site Greenville South Carolina 29605 —
IONIS Investigative Site Ladson South Carolina 29456 —
IONIS Investigative Site Nashville Tennessee 37203 —
IONIS Investigative Site Abilene Texas 79606 —
IONIS Investigative Site Arlington Texas 76012 —
IONIS Investigative Site Austin Texas 78705 —
IONIS Investigative Site Bellaire Texas 77401 —
IONIS Investigative Site Dallas Texas 75231 —
IONIS Investigative Site McAllen Texas 78503 —
IONIS Investigative Site San Antonio Texas 78240 —
IONIS Investigative Site Southlake Texas 76051 —
IONIS Investigative Site The Woodlands Texas 77384 —
IONIS Investigative Site Willow Park Texas 76087 —
IONIS Investigative Site Salt Lake City Utah 84107 —
IONIS Investigative Site Lynchburg Virginia 24502 —
IONIS Investigative Site Richmond Virginia 23235 —
IONIS Investigative Site Silverdale Washington 98383 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03815825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2025 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03815825 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →